Found 12 matching trials
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Hypoxia-targeted Radiotherapy Boost for GBM NA The purpose of this study is to evaluate the use of dynamic contrast-enhanc...
Show More Location
NYU Langone Health
Learn More & Join Trial
Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma PHASE2 Esophageal squamous cell carcinoma (ESCC) is a common and aggressive malign...
Show More Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Preoperative, Adaptive Radiotherapy Concomitant to Chemotherapy for Rectal Adenocarcinoma (Adaptive Rectal Cancer Trial 02) NA The aim of this clinical study is to increase the rate of pathological resp...
Show More Location
I.R.C.C.S. San Raffaele Hospital
Learn More & Join Trial
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial PHASE2 1\. Efficacy of PULSAR preoperative radiation 2. Evaluate potential of micr...
Show More Location
UT Southwestern Medical Center-Dallas
Learn More & Join Trial
Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer PHASE2 Gastric cancer is a global health issue as the world's fifth most common ma...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophageal Adenocarcinoma PHASE1 Rationale: Esophageal cancer (EC) is the seventh most frequently diagnosed ...
Show More Location
University Medical Center Utrecht
Learn More & Join Trial
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma PHASE2 The purpose of this study is to determine if neoadjuvant therapy to increas...
Show More Status
Active Not Recruiting
Location
University of Arizona
Learn More & Join Trial
Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas NA Soft tissue sarcomas (STS) is generally treated by surgery, followed or pre...
Show More Location
Institut Paoli-Calmettes
Learn More & Join Trial
Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Radiotherapy PHASE2 This is a proof-of-concept phase II trial to assess the safety (as primary ...
Show More Location
AOU Careggi Radiation Oncology Unit
Learn More & Join Trial